Terifay Robert J 4
4 · REGENERON PHARMACEUTICALS INC · Filed Aug 11, 2017
Insider Transaction Report
Form 4
Terifay Robert J
SVP Commercial
Transactions
- Exercise/Conversion
Common Stock
2017-08-10$52.03/sh+1,921$99,950→ 25,214 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-10−1,921→ 0 totalExercise: $52.03Exp: 2021-12-16→ Common Stock (1,921 underlying)
Holdings
- 1,699(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.